Latest News


Filter by tags: Medication Clear all tag filters

5 news articles found

Europe must take action to maintain the current level of medical radioisotopes supply, according to a joint position paper from Foratom, the European nuclear trade body, and Nuclear Medicine Europe, which represents pharmaceutical and imaging equipment companies in the field of nuclear medicine. They say the European Union should promote new research reactor capacity along with innovation in the sector and the design modification of the current fleet.

Date: Wednesday, 16 June 2021
Original article:

Rusatom Healthcare, part of state nuclear corporation Rosatom, will build Russia’s first radiopharmaceutical plant to meet global GMP good manufacturing practice standards. The new production facility will be in Obninsk at the site of LYa Karpov Scientific Research Institute of Physics & Chemistry (NIFKhl) and will produce drugs for targeted cancer therapy. The design of pharmaceutical production will be carried out by the Central Design and Technological Institute. Pre-design work is planned to be completed this year, for commissioning in 2024  production in early 2025.

Date: Friday, 07 August 2020
Original article:

A nuclear-derived technique is being used to detect virus causing Covid-19 Real time RT-PCR is the most accurate method to detect the Covid-19 virus. Photo courtesy D. Calma/IAEA. The International Atomic Energy Agency said it has so far delivered more than 250 consignments to 80 countries with supplies to help fight against the coronavirus pandemic, with many more to be shipped in the coming days and weeks.

The agency said its assistance includes equipment and expertise to help laboratories around the world step up testing as part of efforts to curb the spread of the disease.

The effort has drawn around €26m in extrabudgetary funds, including support from IAEA member states and Takeda Pharmaceutical Company Limited, the Japanese multinational pharmaceutical and biopharmaceutical company. Last month Takeda said it would commit around €4.35m in support of the initiative.

The agency has been helping countries through the provision of RT-PCR equipment, as well as accessories for testing and sampling. It is also providing personal protective equipment and offering webinars and video guidance for health and laboratory professionals on sample collection and processing.

Date: Friday, 05 June 2020
Original article:

Biopharmaceutical leader Takeda Pharmaceutical Company Limited has committed to donating JPY500 million (around $4.67 million) in support of a global initiative launched by the International Atomic Energy Agency (IAEA) to help countries combat the Covid-19 pandemic.

Date: Friday, 15 May 2020
Original article:



No Tags found.